POEM OF THE WEEK

Each week Dr. Mark Ebell, POEMs Editor, joins Dr. Michael Wilkes, NPR correspondent and Vice-Dean of the UC-Davis Medical School, for a five minute discussion about an important recent POEM. The discussion provides additional depth and insight into the issue covered by the POEM synopsis.

Episode 695: Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms '

Download Episode 695 (mp3, 10.2MB)

Read the Related POEM synopsis. This will require an Essential Evidence Plus subscription.

Poem of the Week Podcast Archive

*Disclaimer:

This website and its contents do not provide and are not intended to provide medical advice, diagnosis or treatment, or substitute for an individual patient assessment based on a qualified health care provider’s evaluation. All information in this website is provided "as is," with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information, and without warranty of any kind, express or implied, including, but not limited to warranties of performance, merchantability and fitness for a particular purpose. Nothing herein shall to any extent substitute for the independent investigations and the sound judgment of the reader. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information, the reader is urged to review and evaluate the information provided on the website and its contents using their best professional judgment. Wiley is not responsible or liable for any advice, course of treatment, diagnosis, or any other information or services, including health care services.

© Copyright 2024 by John Wiley & Sons, Inc. or related companies. All rights reserved.

Web App Version - 1.2.16